Clinical Trials List
2024-12-02 - 2027-12-31
Phase I/II
Recruiting4
ICD-10C90.00
Multiple myeloma not having achieved remission
ICD-10C90.02
Multiple myeloma in relapse
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9203.00
Multiple myeloma, without mention of remission
-
Trial Applicant
Linical
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/06/01
Investigators and Locations
Co-Principal Investigator
- CHENG-HONG TSAI Division of General Internal Medicine
- 田豐銘
- Chien-Chin Lin
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- ZHENG-WEI ZHOU 無
- Cheng-Lun Lai 無
- PO-HSIEN LI
- 曾貫宇 無
- 鄧齡喬 無
- 吳承翰
- HSIN-CHEN LIN 無
- 楊陽生 無
- Kuan-Der Lee
- CHENG-HSIEN LIN 無
- PO-WEI LIAO 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
21 participants
-
Global
21 participants
